Harbin Pharmaceutical Group Co Ltd banner

Harbin Pharmaceutical Group Co Ltd
SSE:600664

Watchlist Manager
Harbin Pharmaceutical Group Co Ltd Logo
Harbin Pharmaceutical Group Co Ltd
SSE:600664
Watchlist
Price: 4.4 CNY -0.9% Market Closed
Market Cap: ¥11.1B

Balance Sheet

Balance Sheet Decomposition
Harbin Pharmaceutical Group Co Ltd

Balance Sheet
Harbin Pharmaceutical Group Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
1 033
957
787
665
1 122
1 347
2 110
1 564
1 979
2 492
1 956
2 017
1 764
2 334
1 820
4 636
3 510
2 048
676
872
1 191
2 064
2 956
3 526
Cash
0
0
0
0
0
0
0
0
0
0
3
1
1
1
1
1
1
1
1
1
1 191
2 064
2 956
3 526
Cash Equivalents
1 033
957
787
665
1 122
1 347
2 110
1 564
1 979
2 492
1 953
2 016
1 763
2 333
1 819
4 635
3 509
2 047
675
871
0
0
0
0
Short-Term Investments
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
1 098
1 176
1 404
1 619
1 785
2 202
2 027
2 415
2 533
2 794
5 113
4 874
5 642
4 541
4 086
3 517
3 626
3 284
4 398
4 760
4 908
5 051
5 185
5 193
Accounts Receivables
819
849
846
928
1 071
1 311
1 191
1 336
1 521
1 727
2 239
2 301
2 619
2 387
2 427
2 957
2 902
2 521
3 339
3 578
3 955
4 089
4 432
4 362
Other Receivables
279
327
558
691
714
891
836
1 079
1 012
1 067
2 874
2 573
3 023
2 154
1 659
560
724
763
1 059
1 182
953
962
753
831
Inventory
1 286
1 185
1 300
1 304
1 732
1 688
1 706
1 825
1 792
2 388
3 197
3 230
3 322
3 343
2 227
1 749
1 731
1 685
2 026
1 862
2 064
1 804
1 924
1 891
Other Current Assets
124
120
185
215
225
156
92
479
247
368
439
675
419
327
210
158
205
186
207
314
570
640
330
368
Total Current Assets
3 540
3 438
3 676
3 802
4 864
5 396
5 935
6 282
6 552
8 041
10 705
10 795
11 148
10 546
8 343
10 059
9 073
7 204
7 307
7 808
8 733
9 560
10 396
10 979
PP&E Net
2 077
2 368
2 717
3 118
3 444
3 534
2 627
2 534
2 579
2 771
4 141
4 142
4 536
4 898
4 604
4 175
3 723
3 374
3 060
2 783
2 835
2 641
2 472
2 420
PP&E Gross
2 077
2 368
2 717
3 118
3 444
3 534
2 627
2 534
2 579
2 771
4 141
4 142
4 536
4 898
4 604
4 175
3 723
3 374
3 060
2 783
2 835
2 641
2 472
2 420
Accumulated Depreciation
890
1 073
1 292
1 491
1 782
2 069
2 164
2 348
2 496
2 695
3 344
3 644
3 846
4 179
4 439
4 817
5 140
5 452
5 693
5 960
5 924
5 654
5 823
6 080
Intangible Assets
89
101
113
137
160
224
144
136
130
178
382
434
436
447
436
432
483
550
528
525
531
492
478
459
Goodwill
0
0
0
0
0
8
0
0
0
0
8
8
8
7
1
1
1
0
0
0
39
39
39
39
Long-Term Investments
54
41
70
436
159
236
600
639
639
651
27
21
50
37
66
33
82
394
1 153
94
82
85
103
87
Other Long-Term Assets
6
4
3
0
4
144
144
91
107
123
204
267
282
307
316
351
337
379
455
637
622
619
624
632
Other Assets
0
0
0
0
0
8
0
0
0
0
8
8
8
7
1
1
1
0
0
0
39
39
39
39
Total Assets
5 766
N/A
5 953
+3%
6 578
+10%
7 493
+14%
8 631
+15%
9 542
+11%
9 450
-1%
9 683
+2%
10 007
+3%
11 763
+18%
15 468
+31%
15 667
+1%
16 460
+5%
16 243
-1%
13 766
-15%
15 053
+9%
13 699
-9%
11 901
-13%
12 503
+5%
11 848
-5%
12 842
+8%
13 436
+5%
14 112
+5%
14 616
+4%
Liabilities
Accounts Payable
591
573
773
900
1 096
1 208
1 066
1 315
1 698
2 134
2 490
2 596
3 217
2 941
2 254
2 620
2 195
2 019
1 970
2 148
2 176
2 338
2 281
2 049
Accrued Liabilities
1 116
1 054
1 167
1 014
1 087
1 480
880
689
799
872
487
572
624
618
632
661
571
564
535
669
644
699
634
658
Short-Term Debt
424
556
545
653
1 341
912
1 845
1 417
963
1 269
1 937
1 690
1 559
1 504
1 165
1 166
1 288
1 742
2 878
3 996
4 371
4 172
4 542
4 585
Current Portion of Long-Term Debt
276
229
172
238
196
220
163
36
36
75
100
101
102
98
98
99
100
101
102
103
140
140
135
141
Other Current Liabilities
485
534
238
152
213
206
221
238
341
532
1 834
1 373
1 493
1 590
1 444
1 524
1 489
667
584
391
524
653
651
672
Total Current Liabilities
2 891
2 947
2 895
2 957
3 933
4 025
4 175
3 695
3 837
4 883
6 848
6 333
6 995
6 751
5 594
6 070
5 643
5 093
6 069
7 307
7 855
8 002
8 243
8 105
Long-Term Debt
283
187
397
602
281
336
165
111
111
69
78
68
59
53
49
49
48
39
37
37
96
77
64
67
Deferred Income Tax
0
2
2
0
0
0
0
0
0
2
2
1
1
1
1
0
0
0
1
2
2
3
7
6
Minority Interest
32
64
91
523
538
651
8
3
4
35
588
696
612
532
430
446
430
415
486
509
573
620
699
739
Other Liabilities
1
1
16
27
25
70
55
88
74
263
524
613
675
668
639
636
527
488
452
514
470
403
376
349
Total Liabilities
3 208
N/A
3 201
0%
3 402
+6%
4 109
+21%
4 776
+16%
5 083
+6%
4 403
-13%
3 897
-11%
4 027
+3%
5 252
+30%
8 039
+53%
7 711
-4%
8 342
+8%
8 005
-4%
6 713
-16%
7 200
+7%
6 648
-8%
6 035
-9%
7 046
+17%
8 368
+19%
8 995
+7%
9 105
+1%
9 388
+3%
9 266
-1%
Equity
Common Stock
531
637
955
1 242
1 242
1 242
1 242
1 242
1 242
1 242
1 615
1 917
1 917
1 917
1 917
2 541
2 550
2 545
2 507
2 507
2 518
2 526
2 521
2 519
Retained Earnings
691
779
1 079
1 246
1 702
2 286
2 878
3 616
3 816
4 338
4 574
5 074
5 211
5 331
4 025
4 813
3 949
3 025
3 132
2 054
2 426
2 890
3 282
3 911
Additional Paid In Capital
1 336
1 336
1 143
895
910
931
926
927
922
930
1 240
965
989
989
1 111
710
791
778
663
663
675
689
685
684
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 753
1 754
1 754
1 758
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
212
238
153
0
0
16
13
4
0
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
330
845
1 744
4
6
6
5
Total Equity
2 559
N/A
2 752
+8%
3 177
+15%
3 384
+7%
3 854
+14%
4 459
+16%
5 046
+13%
5 786
+15%
5 981
+3%
6 510
+9%
7 429
+14%
7 956
+7%
8 118
+2%
8 238
+1%
7 053
-14%
7 852
+11%
7 052
-10%
5 865
-17%
5 457
-7%
3 480
-36%
3 847
+11%
4 331
+13%
4 724
+9%
5 350
+13%
Total Liabilities & Equity
5 766
N/A
5 953
+3%
6 578
+10%
7 493
+14%
8 631
+15%
9 542
+11%
9 450
-1%
9 683
+2%
10 007
+3%
11 763
+18%
15 468
+31%
15 667
+1%
16 460
+5%
16 243
-1%
13 766
-15%
15 053
+9%
13 699
-9%
11 901
-13%
12 503
+5%
11 848
-5%
12 842
+8%
13 436
+5%
14 112
+5%
14 616
+4%
Shares Outstanding
Common Shares Outstanding
2 099
2 099
2 099
2 099
2 099
2 099
2 099
2 099
2 099
2 099
2 099
2 493
2 493
2 493
2 493
2 541
2 550
2 545
2 507
2 507
2 507
2 517
2 519
2 519
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett